New York Life Investment Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-946
Closed -$297K 1331
2023
Q4
$297K Buy
+946
New +$342K ﹤0.01% 1219

Other funds holding AGL

New York Life Investment Management's AGL Position: Q1 2024 in Review

New York Life Investment Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 946 shares — an estimated $297K sold.

New York Life Investment Management first reported a position in AGL in Q4 2023 and held it in 1 quarter. The position peaked at $297K in Q4 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • New York Life Investment Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 946 Agilon Health shares in Q1 2024, an estimated $297K.
  • New York Life Investment Management first reported a position in Agilon Health in Q4 2023 and held it in 1 quarter.
  • New York Life Investment Management's Agilon Health position peaked at $297K in Q4 2023.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.